Previous Close | 8.00 |
Open | 9.00 |
Bid | 12.30 |
Ask | 13.00 |
Strike | 18.00 |
Expire Date | 2022-07-15 |
Day's Range | 8.00 - 9.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Why Rite Aid's (NYSE: RAD) stock pop and raised guidance still aren't enough to get him interested in buying shares. Additionally, with shares down nearly 70% over the past year, is Zoom Video Communications (NASDAQ: ZM) a screaming buy or past its prime? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.
Yahoo Finance Live anchors discuss third-quarter earnings for Walgreens.
PHILADELPHIA, June 30, 2022--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.